Pharmacolog divests part of its operations to RaySearch Laboratories AB
The exercise period for warrants of series TO3 begins today
The subscription price for the exercise of warrants of series TO3 in Pharmacolog has been set at SEK 0.054 per share
Inova Healthcare selects WasteLog™
Pharmacolog receives two DrugLog™ orders for installation in renowned hospitals in Europe.
Pharmacolog publishes interim report January – September 2023
ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON NOVEMBER 15, 2023
Warrants of series TO2 were subscribed to approximately 1.65 percent and Pharmacolog i Uppsala AB receives approximately SEK 6.6 thousand
NOTICE OF EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)
Pharmacolog implements a strategy with the main objective of carrying out an industrial or financial sale.
The website uses necessary cookies to ensure the website functions properly. You can also choose to consent to cookies for statistical purposes.
Search
By requesting this documentation I agree to the terms in Pharmacologs privacy policy
